The Equation Series
Menu

Industry study 03 of 23 · Venture Capital Research Companion

Growth, Late-Stage & Crossover Investing

~6,000 words · 2 technical exhibits

Late-stage venture is where private companies with real revenue, often $50m to several billion dollars, raise $100m-plus rounds before an IPO or sale. The investors are a different crowd: growth funds of multistage firms, crossover hedge funds, mutual funds, sovereign wealth funds, and since 2023 hyperscalers and chip makers funding AI labs. The risk is different too. Most companies at this stage will not fail outright, but price and structure, not company selection alone, decide returns. That lesson was learned at great cost in the 2021 boom and the 2022–23 reset, and it is being tested again by the AI mega-rounds of 2024–26.

What the study covers

  1. 1Overview: what changes after the Series B
  2. 2The players
  3. 3Mechanics
  4. 4Key numbers
  5. 5Landmark deals and cases
  6. 6Pitfalls
  7. 7How an expert thinks about it
  8. 8Glossary
  9. 9Related sections

Technical exhibits

Worked examples, checklists and case studies included with this study.

Crossover Boom and Bust 2021 Case Study

Case study of the 2020–21 crossover boom and the 2022–24 bust: actors, mechanics, valuation round trips, the multiple-compression math and lessons for the AI cycle

Late Stage Structured Terms Worked Example

A $250m Series E at a $5bn headline: underwriting returns, an IPO ratchet and a senior preference across exit scenarios (computed in Python)